These biochemical and immunohistochemically analyses indicate a temporal causal relationship between Artemether therapy and reduced amyloid-β deposition and phosphorylation of tau pathologies in 3xTg-AD mice. This evidence concerns the gene MAPT and Alzheimer disease.